{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
<< Back to Michigan Medicine
Client Logo
  • Sign In
  • Live Courses
  • RSS
  • On Demand
  • Planning Guide
  • About
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

If you are employed by the University of Michigan, you automatically have a MiCME account. You can Sign In using your University of Michigan username and password.

If you are not an employee of the University of Michigan, sign in below with the username and password used to create your account. If you have never Signed In,  please create an account by clicking on the red "Sign Up Now" button below. 

UM Sign In
Non-UM Sign In
Enter your email and password to login:

*
*
Login

New to MiCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • BSN
  • BSN, RN
  • CNM
  • CRNA
  • DDS
  • DMD
  • DO
  • DPM
  • DPT
  • JD
  • LCSW
  • LPN
  • MA
  • MBBS
  • MD
  • MD, MPH
  • MD, PhD
  • MHA
  • MPH
  • MS
  • MSN
  • MSN, NP
  • MSN, RN
  • MSW
  • None
  • NP
  • OD
  • Other
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RN
Degree is required
Please enter your degree:
You must enter a degree

Profession is required

User Agreement

This form collects name, email address and other contact information so our support team can communicate and provide assistance. Please check our Privacy Policy to see how we protect and manage submitted data. By creating a MiCME powered by CloudCME account, you agree to have your contact information collected via this form. You must also consent below.


You must agree to the terms and conditions before registering.




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Emerging Paradigms in Liver Cancer Diagnosis and Treatment

  • Overview
  • Register
  • Faculty
  • Schedule
  • Brochure
Add to Calendar Emerging Paradigms in Liver Cancer Diagnosis and Treatment 3/15/2025 8:00:00 AM 3/15/2025 3:00:00 PM America/New_York For More Details: https://umich.cloud-cme.com/course/courseoverview?EID=4039 Description: We are happy to host the 2025 Emerging Paradigms in Liver Cancer Diagnosis and Treatment in person this year at the Westin Southfield Detroit in Southfield, MI. The full-day conference will focus on the full spectrum of primary liver cancers, from early detection, diagnosis, to novel cutting-edge treatments. The program will feature University of Michigan faculty members, with ample opportunities for di... The Westin Southfield / Virtual false MM/DD/YYYY


Date & Location
Saturday, March 15, 2025, 8:00 AM - 3:00 PM EST, The Westin Southfield / Virtual, Southfield, MI

Target Audience
Specialties - Hematology/Oncology, Hepatology, Medical Oncology, Pathology, Radiation Oncology, Surgery, Transplant Surgery
Professions - Medical Student, Nurse, Nurse Practitioner, Other Healthcare Professional, Physician, Physician Assistant

Credits
AMA PRA Category 1 Credits™ (5.25 hours), Non-Physician Attendance (5.25 hours)

Overview
We are happy to host the 2025 Emerging Paradigms in Liver Cancer Diagnosis and Treatment in person this year at the Westin Southfield Detroit in Southfield, MI. The full-day conference will focus on the full spectrum of primary liver cancers, from early detection, diagnosis, to novel cutting-edge treatments. The program will feature University of Michigan faculty members, with ample opportunities for discussion and interactions. At the end of this activity, medical professionals will utilize adequate surveillance for hepatocellular carcinoma in patients who are at risk and adequately treat hepatocellular carcinoma and cholangiocarcinoma. They will also identify populations that are appropriate for liver cancer screening and use up to date evidence on approved treatments for primary liver cancers. Patients will also receive up to date treatments for primary liver cancer.

Accreditation

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
AMA PRA Category 1 

The University of Michigan Medical School designates this Live Activity for a maximum of 5.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information

Accessibility Statement
The University of Michigan Medical School is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Activity Coordinator.

Questions? Please contact Matt Roche or Georgina Koch



Keywords: LIVEAMAFeatured



Mitigation of Relevant Financial Relationships


The University of Michigan Medical School adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, or others are required to disclose all relevant financial relationships with ineligible entities. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Vaibhav Sahai, MBBS
MBBS, MS
University of Michigan
Educational Co-Planner, Faculty
Consulting Fee-Delcath (Relationship has ended)|Consulting Fee-Elevar|Consulting Fee- Incyte|Consulting Fee-Jazz|Consulting Fee-HistoSonics|Grant or research support-Bristol-Myers Squibb|Grant or research support-Jazz
Christopher J Sonnenday, MD
MD
MICHIGAN MEDICINE
Educational Co-Planner, Faculty
Nothing to disclose
Neehar D Parikh, MD
MD
University of Michigan
Educational Planner, Faculty
Consulting Fee-Exelixis, Inc.|Advisor-AstraZeneca (Any division) (Relationship has ended)|Consulting Fee-Exact Sciences|Consulting Fee-Sirtex (Relationship has ended)|Honoraria-Fujifilm Medical (Relationship has ended)
Jared A Christensen, MD
MD
University of Michigan
Faculty
Nothing to disclose
Oxana V Crysler, MD,M.D.
MD,M.D.
Michigan Medicine
Faculty
Grant or research support-AstraZeneca (Any division) (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Bayer (Any division)|Grant or research support-Eisai, Inc.|Grant or research support-Merck (Any division)
Kyle Cuneo, MD
Professor
Michigan Medicine
Faculty
Nothing to disclose
Benjamin Ferguson, MD,PhD
MD,PhD
University of Michigan
Faculty
Nothing to disclose
Laura Kulik, MD, Professor
MD
Northwestern
Faculty
Honoraria-AstraZeneca (Any division)|Honoraria-Eisai, Inc. (Relationship has ended)|Advisor-AstraZeneca (Any division)|Consulting Fee-AstraZeneca (Any division)
Alisa Likhitsup, MD,MPH
MD,MPH
University of Michigan
Faculty
Nothing to disclose
Mishal Mendiratta-Lala, MD
MD
Michigan Medicine
Faculty
Honoraria-Society of Interventional Radiology (Relationship has ended)
Arathi Mohan, MD
MD
University of Michigan
Faculty
Grant or research support-Verastem Oncology
Nataliya Razumilava, M.D., Assistant Professor
Assistant Professor
University of Michigan
Faculty
Other: Pi for the clinical trial-NGM Bio

Saturday, March 15, 2025

Emerging Paradigms in Liver Cancer Diagnosis and Treatment (Sat, 9/28/24)

Novel Liquid Biopsy and Imaging Based Screening for HCC –
8:00AM - 8:20AM
Neehar D Parikh, MD
Management of PSC and Risk of Cholangiocarcinoma
8:20AM - 8:40AM
Nataliya Razumilava, M.D., Assistant Professor
Assessing and Preserving Liver Function in Patients with HCC
8:40AM - 9:00AM
Alisa Likhitsup, MD,MPH
Histotripsy for HCC and Liver Tumors
9:00AM - 9:20AM
Mishal Mendiratta-Lala, MD
Combining LRT and Systemic Therapy for HCC – Recent Evidence and the Horizon
9:20AM - 9:40AM
Jared A Christensen, MD
Adaptive Radiotherapy – Preserving Liver Function while Controlling Tumor
9:40AM - 10:00AM
Kyle Cuneo, MD
Radioembolization for HCC – Treatment of Choice Across all Stages
10:00AM - 10:30AM
Laura Kulik, MD, Professor
Break
10:30AM - 11:00AM
Transplantation for Cholangiocarcinoma and Colorectal Metastases
11:00AM - 11:20AM
Christopher J Sonnenday, MD
Surgical Therapies and Hepatic Arterial Pumps for Metastatic Tumors of the Liver
11:20AM - 11:40AM
Benjamin Ferguson, MD,PhD
Case Discussion
11:40AM - 12:15PM
Lunch
12:15PM - 1:00PM
Sequencing Systemic Therapies for Hepatocellular Carcinoma
1:00PM - 1:20PM
Oxana V Crysler, MD,M.D.
Systemic Treatment of Advanced Biliary Cancer
1:20PM - 1:40PM
Vaibhav Sahai, MBBS
The Future of immunotherapy for HCC
1:40PM - 2:00PM
Arathi Mohan, MD
Q&A and Wrap Up
2:00PM - 2:30PM

Office of Continuing Medical Education and Lifelong Learning
1600 Huron Parkway Building #400
Ann Arbor, MI 48109-2800

©1995-2024 Regents of the University of Michigan Privacy Policy | Disclaimer | Non-Discrimination
ACCME Accreditation with Commendation

Powered By CloudCME